At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Alcon Opti-Free® RepleniSH® with Supraclens® +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens
In Brief
A clinical study evaluating Alcon Opti-Free® RepleniSH® with Supraclens®, Alcon Opti-Free® RepleniSH®, and 1 other intervention for Ametropia. Completed, enrolled 76 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if reduced lens deposits and increased comfort can be achieved by using Multipurpose disinfecting solutions (MPDS) in a no-rub format but in conjunction with an intensive cleaner, rather than using MPDS in a rub format.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia
CountriesCanada
CollaboratorsAlcon Research
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
Primary CompletionJul 2008
Study CompletionSep 2008
First PostedSep 2008
TodayJul 2026
First PostedSep 18, 2008
Enrollment StartJan 1, 2008
Primary CompletionJul 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.8 years ago
Interventions
Alcon Opti-Free® RepleniSH® with Supraclens®drug
Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover
Alcon Opti-Free® RepleniSH®drug
Marketed Multipurpose Disinfecting Care System
B&L ReNu MultiPlus™drug
Marketed Multipurpose Disinfecting Care Systems